Erin M. Corsini

Erin M. Corsini

Auto-generated profile, based on publicly available information

Erin M. Corsini

Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2012 in JAMA
Verified
Journal Article
Open access
PDF file
SSSharath Subramanian
Sharath Subramanian
ATAhmed Tawakol
Ahmed Tawakol
TBTricia H. Burdo
Tricia H. Burdo
SASuhny Abbara
Suhny Abbara
JWJeffrey Wei
Jeffrey Wei
SGSteven K. Grinspoon
Steven K. Grinspoon
Coronary artery disease (CAD) is significantly increased in patients infected with human immunodeficiency virus (HIV), but the specific mechanisms remain unknown.1 Immunological modulations may play an important role in the pathogenesis of atherosclerosis in patients with HIV. Patients with HIV demonstrate a high prevalence of noncalcified coronary atherosclerotic lesions that are increased in association with markers of macrophage activation.2 This is significant because infiltration of activated monocytes and macrophages into the endothelium contributes to the development of vulnerable atherosclerotic plaque susceptible to rupture.3,4

1 December 2013 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
AFAmparo L. Figueroa
Amparo L. Figueroa
AAAmr Abdelbaky
Amr Abdelbaky
QTQuynh A. Truong
Quynh A. Truong
ECErin Corsini
Erin Corsini
MMMegan H. MacNabb
Megan H. MacNabb
ATAhmed Tawakol
Ahmed Tawakol

10 May 2020 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SLSteven Lin
Steven Lin
BHBrian P. Hobbs
Brian P. Hobbs
VVVivek Verma
Vivek Verma
RTRebecca S. Tidwell
Rebecca S. Tidwell
GSGrace L. Smith
Grace L. Smith
RMRadhe Mohan
Radhe Mohan
PURPOSE: Whether dosimetric advantages of proton beam therapy (PBT) translate to improved clinical outcomes compared with intensity-modulated radiation therapy (IMRT) remains unclear. This randomized trial compared total toxicity burden (TTB) and progression-free survival (PFS) between these modalities for esophageal cancer. METHODS: This phase IIB trial randomly assigned patients to PBT or IMRT (50.4 Gy), stratified for histology, resectability, induction chemotherapy, and stage. The prespecified coprimary end points were TTB and PFS. TTB, a composite score of 11 distinct adverse events (AEs), including common toxicities as well as postoperative complications (POCs) in operated patients, quantified the extent of AE severity experienced over the duration of 1 year following treatment. The trial was conducted using Bayesian group sequential design with three planned interim analyses at 33%, 50%, and 67% of expected accrual (adjusted for follow-up). RESULTS: This trial (commenced April 2012) was approved for closure and analysis upon activation of NRG-GI006 in March 2019, which occurred immediately prior to the planned 67% interim analysis. Altogether, 145 patients were randomly assigned (72 IMRT, 73 PBT), and 107 patients (61 IMRT, 46 PBT) were evaluable. Median follow-up was 44.1 months. Fifty-one patients (30 IMRT, 21 PBT) underwent esophagectomy; 80% of PBT was passive scattering. The posterior mean TTB was 2.3 times higher for IMRT (39.9; 95% highest posterior density interval, 26.2-54.9) than PBT (17.4; 10.5-25.0). The mean POC score was 7.6 times higher for IMRT (19.1; 7.3-32.3) versus PBT (2.5; 0.3-5.2). The posterior probability that mean TTB was lower for PBT compared with IMRT was 0.9989, which exceeded the trial’s stopping boundary of 0.9942 at the 67% interim analysis. The 3-year PFS rate (50.8% v 51.2%) and 3-year overall survival rates (44.5% v 44.5%) were similar. CONCLUSION: For locally advanced esophageal cancer, PBT reduced the risk and severity of AEs compared with IMRT while maintaining similar PFS.

1 March 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CBClaire E. Bamberg
Claire E. Bamberg
CMCharles R. Mackay
Charles R. Mackay
HLHyun Lee
Hyun Lee
DZDavid Zahra
David Zahra
JJJenny Jackson
Jenny Jackson
NGNorma P. Gerard
Norma P. Gerard
The complement anaphylatoxin C5a is a proinflammatory component of host defense that functions through two identified receptors, C5a receptor (C5aR) and C5L2. C5aR is a classical G protein-coupled receptor, whereas C5L2 is structurally homologous but deficient in G protein coupling. In human neutrophils, we show C5L2 is predominantly intracellular, whereas C5aR is expressed on the plasma membrane. Confocal analysis shows internalized C5aR following ligand binding is co-localized with both C5L2 and β-arrestin. Antibody blockade of C5L2 results in a dramatic increase in C5a-mediated chemotaxis and ERK1/2 phosphorylation but does not alter C5a-mediated calcium mobilization, supporting its role in modulation of the β-arrestin pathway. Association of C5L2 with β-arrestin is confirmed by cellular co-immunoprecipitation assays. C5L2 blockade also has no effect on ligand uptake or C5aR endocytosis in human polymorphonuclear leukocytes, distinguishing its role from that of a rapid recycling or scavenging receptor in this cell type. This is thus the first example of a naturally occurring seven-transmembrane segment receptor that is both obligately uncoupled from G proteins and a negative modulator of signal transduction through the β-arrestin pathway. Physiologically, these properties provide the possibility for additional fine-tuning of host defense.

1 September 2013 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
AAAmr Abdelbaky
Amr Abdelbaky
ECErin Corsini
Erin Corsini
AFAmparo L. Figueroa
Amparo L. Figueroa
SFSara Fontanez
Sara Fontanez
SSSharath Subramanian
Sharath Subramanian
ATAhmed Tawakol
Ahmed Tawakol
Background—: Arterial calcium (Ca) deposition has been identified as an active inflammatory process. We sought to test the hypothesis that local vascular inflammation predisposes to subsequent arterial calcium deposition in humans. Methods and Results—: From a hospital database, we identified 137 patients (age, 61±13 years; 48.1% men) who underwent serial positron-emission tomography/computed tomography (1–5 years apart). Focal arterial inflammation was prospectively determined by measuring 18F-flourodeoxyglucose uptake (using baseline positron-emission tomography) within predetermined locations of the thoracic aortic wall and was reported as a standardized uptake value. A separate, blinded investigator evaluated calcium deposition (on the baseline and follow-up computed tomographic scans) along the same standardized sections of the aorta. New calcification was prospectively defined using square root–transformed difference of calcium volume score, with a cutoff value of 2.5. Accordingly, vascular segment was classified as either with or without subsequent calcification. Overall, 67 (9%) of aortic segments demonstrated subsequent calcification. Baseline median (interquartile range) standardized uptake value was higher in segments with versus without subsequent calcification (2.09 [1.84–2.44] versus 1.92 [1.72–2.20], P =0.002). This was also true in the subset of segments with Ca present at baseline (2.08 [1.81–2.40] versus 1.86 [1.66–2.09], P =0.02), as well as those without (2.17 [1.87–2.51] versus 1.93 [1.73–2.20], P =0.04). Furthermore, across all patients, subsequent Ca deposition was associated with the underlying 18F-flourodeoxyglucose uptake (inflammatory signal), measured as standardized uptake value (odds ratio [95% confidence interval]=2.94 [1.27–6.89], P =0.01) or target-to-background ratio (2.59 [1.18–5.70], P =0.02), after adjusting for traditional cardiovascular risk factors. Conclusions—: Here, we provide first-in-man evidence that arterial inflammation precedes subsequent Ca deposition, a marker of plaque progression, within the underlying location in the artery wall.

1 February 2015 in Atherosclerosis
Verified
Journal Article
Closed access
AAAmr Abdelbaky
Amr Abdelbaky
ECErin Corsini
Erin Corsini
AFAmparo L. Figueroa
Amparo L. Figueroa
SSSharath Subramanian
Sharath Subramanian
SFSara Fontanez
Sara Fontanez
ATAhmed Tawakol
Ahmed Tawakol